Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3296 QN523Summary: QN523, a novel scaffold with activity-like molecular properties, showed potent in vitro cytotoxicity in 12 cancer cell lines. -
BA3297 BBR-BODIPYSummary: BBR-BODIPY is a fluorescent probe that can be screened for its interaction with target cells. -
BA3299 GK563Summary: GK563 is a selective Ca-independent inhibitor. -
BA3300 PeruvosideSummary: Peruvoside induces apoptosis and autophagy and has broad-spectrum antitumor activity in breast, lung, liver and leukemia. -
BA3301 NemorosoneSummary: Nemorosone is the main component of the resin. -
BA3302 PT-262Summary: PT-262 is a potent inhibitor with a value of approximately 5 μM. -
BA3303 DD1Summary: DD1 is a proteasome inhibitor activated during apoptosis in acute myeloid leukemia (AML) that degrades P70S6K. -
BA3304 GalgravinSummary: Galgravin is one of the active compounds in and has anti-inflammatory properties. -
BA3305 ZPCKSummary: ZPCK is a precursor of gemcitabine. -
BA3306 ToddaculinSummary: Toddaculin is a natural coumarin that induces differentiation and apoptosis in leukemia cells.


